Denis Maxime, Landry Yves D, Zha Xiaohui
Ottawa Health Research Institute, and Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ontario K1Y 4E9, Canada.
J Biol Chem. 2008 Jun 6;283(23):16178-86. doi: 10.1074/jbc.M709597200. Epub 2008 Apr 1.
ATP-binding cassette transporter (ABC) A1 is required for the lipidation of apolipoprotein A-I to generate high density lipoprotein (HDL). This process is proposed to occur through a retro-endocytosis pathway in which apoA-I internalizes with ABCA1 and generates HDL from the endosomal compartments before resecretion. The aim of this study was to determine the route of apoA-I endocytosis and whether endocytosis contributes to HDL biogenesis. Using confocal microscopy, we found that internalized apoA-I only transiently colocalized with transferrin, a retro-endocytosis marker. Instead, apoA-I perfectly colocalized with a bulk phase uptake marker (fluorescein isothiocyanate-dextran) and, at later time points, with LysoTracker in several cell models including macrophages, fibroblasts, and baby hamster kidney cells. ABCA1 colocalized poorly with internalized apoA-I. To determine the contribution of internalized apoA-I to HDL biogenesis, we specifically removed apoA-I from the cell surface and analyzed the fate of internalized apoA-I. We found that 23% of cell-associated apoA-I was internalized at steady state. Of internalized apoA-I, only 20% was converted to HDL, and the rest was degraded, consistent with a lysosomal destination. We also found that apoA-I was released approximately five times faster from the plasma membrane than from the intracellular compartments. From these kinetic parameters, we estimated that approximately 5.6% of apoA-I that interacts with cells is degraded and that internalized apoA-I contributes to approximately 1.4% of total HDL production. We also found that blocking endocytosis with sucrose or cytochalasin D did not decrease cholesterol efflux or HDL biogenesis. We therefore conclude that the plasma membrane is the main platform where ABCA1-mediated lipidation of apoA-I occurs.
载脂蛋白A-I的脂化过程需要ATP结合盒转运蛋白(ABC)A1参与以生成高密度脂蛋白(HDL)。该过程被认为是通过逆向胞吞途径发生的,即载脂蛋白A-I与ABCA1一起内化,并在内体区室中生成HDL后再分泌。本研究的目的是确定载脂蛋白A-I的内吞途径以及内吞作用是否有助于HDL的生物合成。利用共聚焦显微镜,我们发现内化的载脂蛋白A-I仅与逆向胞吞标志物转铁蛋白短暂共定位。相反,在包括巨噬细胞、成纤维细胞和幼仓鼠肾细胞在内的几种细胞模型中,载脂蛋白A-I与大量相摄取标志物(异硫氰酸荧光素-葡聚糖)完美共定位,并且在稍后的时间点与溶酶体追踪染料共定位。ABCA1与内化的载脂蛋白A-I共定位较差。为了确定内化的载脂蛋白A-I对HDL生物合成的贡献,我们特异性地从细胞表面去除载脂蛋白A-I,并分析内化的载脂蛋白A-I的去向。我们发现,在稳态下,23%的细胞相关载脂蛋白A-I被内化。在内化的载脂蛋白A-I中,只有20%转化为HDL,其余的被降解,这与溶酶体的去向一致。我们还发现,载脂蛋白A-I从质膜释放的速度比从细胞内区室释放的速度快约五倍。根据这些动力学参数,我们估计与细胞相互作用的载脂蛋白A-I中约5.6%被降解,内化的载脂蛋白A-I对总HDL产生的贡献约为1.4%。我们还发现,用蔗糖或细胞松弛素D阻断内吞作用不会降低胆固醇流出或HDL生物合成。因此,我们得出结论,质膜是ABCA1介导的载脂蛋白A-I脂化发生的主要平台。